Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
X
Xiang, Tianyi
University of Minnesota
(
T1030-04-22
)
Structure-Mechanical Property Relationship in Molecular Crystals for Predicting Tabletability
Tianyi Xiang
Favorite
(
W1230-10-57
)
Efficient Development of High Drug-Loaded Posaconazole Tablets Enabled by Amorphous Solid Dispersion
Tianyi Xiang
Favorite
Xiao, Yingwen
Moderna, Inc.
(
M0930-02-10
)
Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Yingwen Xiao
Favorite
Xiaoyu, Ji
Chinese University of Hong Kong, The
(
W0930-04-24
)
Kidney Metabolomics Demonstrated the Energy Supply Upregulation by
Radix Aconiti Lateralis
Preparations in Rats
Ji Xiaoyu
Favorite
Xia, Qiang
ICE Bioscience
(
M1030-04-19
)
Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Qiang Xia
Favorite
Xie, Huan
Texas Southern University
(
T1330-09-48
)
Controllable Microfluidic Synthesis of Drug-Loaded PLGA/PEG Nanoparticles Using DoE Approaches with Versatile Flow Streams
Huan Xie
Favorite
Xie, Jiashu
University of Minnesota
(
W1130-04-19
)
GSH-Dependent Inhibition of Multidrug Resistance-Associated Protein 1 (MRP1) by ZW-1226
Jiashu Xie
Favorite
Xie, Lingxiao
US Food and Drug Administration
(
T1030-09-48
)
Understanding Critical Quality Attributes of Gelatin Coated Miconazole Nitrate Vaginal Inserts and Suppositories
Lingxiao Xie
Favorite
(
W1130-01-02
)
Bioequivalence Approaches Utilized in Generic Drug Applications for Topical Drug Products Applied to the Skin
Lingxiao Xie
Favorite
Xie, Zuoxu
Biogen
(
W1030-06-35
)
Pharmacologically Active Drug Metabolites: Impact on Drug Discovery
Zuoxu Xie
Favorite
Xin, Benjamin
WuXi AppTec Co., Ltd.
(
M1030-04-21
)
Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Benjamin Xin
Favorite
Xing, Kuiyi
Celerion
(
W1030-06-34
)
Stabilization of a Therapeutic Peptide for a Quantitative ECLIA Assay
Kuiyi Xing
Favorite
Xing, Lili
WuXi AppTec (Shanghai) Co., Ltd.
(
M1030-06-36
)
Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Lili Xing
Favorite
(
W1030-06-36
)
Development of a Rapid, High Throughput Quantitative Bioanalysis of Conjugated Payloads of Protease-Cleavable Antibody-Drug Conjugate (ADC) in Rat Serum Using Automated Immunocapture Based UPLC-MS/MS
Lili Xing
Favorite
Xin, Lun
Wuxi Biologics
(
T1030-10-58
)
Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies
Lun Xin
Favorite
Xi, Zhangjie
Bayer Consumer Care
(
M1230-01-03
)
Dual-Drug Ionic Liquid Complex Dextromethorphan Naproate with Enhancement of Physico-Chemical Properties than Parent Molecules
Zhangjie Xi
Favorite
(
T1530-03-13
)
Delineating the Effect of Commonly Used Surfactant/Cosurfactant Compositions Affecting the Dispersion Characteristics of Aqueous-Based Nasal Sprays
Zhangjie Xi
Favorite
(
W1030-03-13
)
Role of Polyethylene Glycol and Propylene Glycol in Modulating the Spreadability and 3-D Structure of a Carbomer Based Nasal Gel
Zhangjie Xi
Favorite
(
W1230-01-02
)
Novel Use of Excised Bovine Stomach to Study Mucoadhesive and Rheological Synergism Properties of Gastro-Retentive Antacid Formulations
Zhangjie Xi
Favorite
Xue, Liang
University of the Pacific
(
M1130-01-06
)
Role of Temperature in the Formation of Solid Micellar-Size Nanoparticles of Nonionic Polyoxyethylated Amphiphiles
Liang Xue
Favorite
Xue, Zheng
University of Minnesota
(
W1230-04-24
)
Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Zheng Xue
Favorite
Xu, Guo
IMCD
(
T1130-03-15
)
Investigations on Formulation and Process Effects on Avicel
®
RC-591 Rheological Performance in Suspensions
Guo Xu
Favorite
Xu, Haiyue
University of Texas at Austin
(
T1030-10-57
)
Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Haiyue Xu
Favorite
Xu, Jianchao
Purdue University
(
T1430-11-60
)
Determining Impact of Particle Size and Crystal Quality on Formation of Nitrosamine in API and Drug Formulations
Jianchao Xu
Favorite
Xu, Miao
Chinese University of Hong Kong, The
(
M1230-01-05
)
Immobilization of Depolymerase Coating with Lay Down Bactericidal Activity on Biomedical Implants
Miao Xu
Favorite
Xu, Qingguo
Virginia Commonwealth University
(
T1030-03-14
)
Novel Microemulsion-Based Fenofibrate Eyedrop for Treating Nitrogen Mustard-Induced Corneal Injury
Qingguo Xu
Favorite
(
T1430-07-41
)
Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Qingguo Xu
Favorite
(
W1130-11-64
)
Reverse Engineering of the Sublocade
®
Buprenorphine In Situ Forming Implant
Qingguo Xu
Favorite
Xu, Shuyu
Ashland Specialty Ingredients
(
W1130-03-13
)
Powerful Tools for Precise Engineering of Viatel
TM
Diblock Nanoparticle Size: Polymer and Solvent Structure
Shuyu Xu
Favorite
Xu, Weifeng
Merck & Co., Inc.
(
M1030-06-31
)
Utilizing LC-MS to Support of PABAD-Based Detection of Neutralizing Antibodies
Weifeng Xu
Favorite
Xu, Wenqin
WuXi AppTec Co., Ltd.
(
W0930-06-31
)
Simultaneous Quantification of Multiple ADC Component Concentrations and DAR Profiling with One Aliquot of Plasma in NHP Toxicology Study by Hybrid LC-MS
Wenqin Xu
Favorite
Xu, Xiaolin
University of Washington
(
W1230-10-58
)
A Stable and Scalable Gemcitabine and Paclitaxel Drug Combination Nanoparticle (DcNP) Exhibits Long-Acting Pharmacokinetics and Breast Tumor Regression in an Orthotopic 4T1 Mouse Model
Xiaolin Xu
Favorite
Xu, Xiaoming
US Food and Drug Administration
(
T1530-11-60
)
Evaluation of Near Infrared (NIR) for the Quantitation of Low Dose Drugs
Xiaoming Xu
Favorite
Xu, Yueqiang
ICE Bioscience
(
M1030-04-19
)
Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Yueqiang Xu
Favorite
Xu, Yunming
US Food and Drug Administration
(
M1130-11-61
)
Development of Biorelevant Dissolution Methods for Potential Risk-Based Biowaivers of BCS Class IIa Compounds: Impact of pH, Buffer Capacity and Hydrodynamics of Dissolution Media
Yunming Xu
Favorite
(
T1530-02-07
)
Establishing a Dissolution Safe Space for Ibuprofen as a Model BCS Class IIa Drug Using Product Particle Size Distribution (P-PSD) Approaches to Support Biowaiver Consideration
Yunming Xu
Favorite
Xu, Zijing
University of Florida College of Pharmacy
(
M0930-03-13
)
Tuning the Organ Selectivity of mRNA Expression through Dendrimer-Based Lipid Nanoparticles
Zijing Xu
Favorite
(
T1430-04-20
)
In Situ Engineering of Tumor-Infiltrating Myeloid Cells Through Dendrimer-Based Lipid Nanoparticles
Zijing Xu
Favorite
Xu, Zizhao
University of the Pacific
(
T1330-09-52
)
Co-Formulation of Vinorelbine and Doxorubicin into Liposomes for the Treatment of Non-Small Cell Lung Cancer
Zizhao Xu
Favorite
